Fmr LLC Has $2.55 Billion Stake in Intuitive Surgical, Inc. (ISRG)
Fmr LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,724,964 shares of the medical equipment provider’s stock after buying an additional 447,397 shares during the period. Fmr LLC owned about 7.34% of Intuitive Surgical worth $2,548,849,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. D. Scott Neal Inc. acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $120,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $120,000. Guardian Life Insurance Co. of America raised its position in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the last quarter. Parallel Advisors LLC raised its position in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the last quarter. Finally, Flagship Harbor Advisors LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $221,000. 94.23% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical, Inc. (NASDAQ ISRG) traded down 1.18% during midday trading on Thursday, hitting $1034.02. 61,698 shares of the stock traded hands. The company has a 50-day moving average price of $990.40 and a 200-day moving average price of $891.23. Intuitive Surgical, Inc. has a 1-year low of $610.71 and a 1-year high of $1,054.77. The firm has a market cap of $38.41 billion, a P/E ratio of 49.53 and a beta of 0.38. Intuitive Surgical’s stock is set to split before the market opens on Friday, October 6th. The 3-1 split was announced on Friday, August 11th. The newly created shares will be distributed to shareholders after the market closes on Thursday, October 5th.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.05. The firm had revenue of $756.20 million for the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.87 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post $23.92 EPS for the current year.
In related news, CEO Gary S. Guthart sold 17,975 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the transaction, the chief executive officer now owns 101,798 shares of the company’s stock, valued at $95,412,211.46. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael A. Friedman sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $945.60, for a total transaction of $945,600.00. Following the transaction, the director now directly owns 977 shares in the company, valued at approximately $923,851.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,172 shares of company stock worth $21,923,487. Insiders own 2.20% of the company’s stock.
A number of equities analysts have recently weighed in on ISRG shares. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $333.00 price objective for the company in a research report on Wednesday, May 24th. Bank of America Corporation reissued a “buy” rating and issued a $333.33 price objective on shares of Intuitive Surgical in a research report on Thursday, June 1st. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Stifel Nicolaus reissued a “buy” rating and issued a $366.67 price objective (up previously from $283.33) on shares of Intuitive Surgical in a research report on Saturday, July 22nd. Finally, Citigroup Inc. reissued a “buy” rating and issued a $359.33 price objective (up previously from $305.67) on shares of Intuitive Surgical in a research report on Monday, July 24th. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $366.12.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.